Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

Venous Thromboembolism

  • Article

    Consider post-discharge VTE prophylaxis for COVID-19 patients

    April 1, 2022

    Dr. Indovina Clinical question: Should extended post-discharge venous thromboembolism (VTE) prophylaxis be prescribed for patients with COVID-19? Background: While VTE prophylaxis during...

  • Article

    Higher-than-expected recurrent VTE found in patients with isolated SSPE

    April 1, 2022

    Dr. Munoa Clinical question: What is the recurrence rate of venous thromboembolism (VTE) in patients with isolated subsegmental pulmonary embolisms (SSPE) managed without...

  • Article

    Direct oral anticoagulants may be safe in cancer-related venous thromboembolisms, but use caution with gastrointestinal malignancies

    February 3, 2022

    Clinical question: Are direct oral anticoagulants (DOACs) a suitable alternative to low molecular weight heparin (LMWH) for treatment of venous thromboembolism (VTE) in patients with underlying...

  • News

    D-dimer thresholds rule out PE in meta-analysis

    December 14, 2021

    Data from a large review support use of D-dimer levels to diagnose PE without imaging.

  • 1
    News

    Apixaban outmatches rivaroxaban for VTE in study

    December 6, 2021

    These real-world findings may guide selection of initial anticoagulant therapy, according to authors of the paper.

  • News

    D-dimer unreliable for ruling out pulmonary embolism in COVID-19

    October 14, 2021

    “These results suggest that use of D-dimer levels to exclude PE among patients hospitalized with COVID-19 may be inappropriate and have limited clinical utility.”

  • News

    Rivaroxaban’s single daily dose may lead to higher bleeding risk than other DOACs

    October 11, 2021

    Corroborating previous studies, Iceland researchers report that rivaroxaban poses the highest risk of GI bleeding, compared with other DOACs.

  • 1
    News

    Refined heart rate cutoffs may improve prognostic value of acute PE scoring systems

    September 21, 2021

    In an observational registry-based study, dropping the 110-bpm heart rate threshold improved sensitivity for low-risk PE, while increasing it improved specificity for intermediate-high–risk PE.

  • News

    Study gives bleeding risk estimates for VTE patients on anticoagulants

    September 13, 2021

    New research provides best available estimates of long-term bleeding risk with different anticoagulants, authors say.

  • News

    Prophylactic anticoagulation tied to lower death rate in COVID

    June 18, 2021

    Prophylactic use of low-dose anticoagulation to prevent venous thromboembolism was associated with reduced 60-day mortality in patients hospitalized with COVID-19 in Michigan.

1 2 3Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2000-2023 by the Society of Hospital Medicine and related companies. All rights reserved. ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences